到 2027 年北美结直肠癌市场 - 按模式（诊断类型、治疗类型、影像类型）进行区域分析和预测；最终用户（医院、诊断和研究实验室）和国家/地区
No. of Pages: 157 | Report Code: TIPRE00009241 | Category: Life Sciences
No. of Pages: 157 | Report Code: TIPRE00009241 | Category: Life Sciences
北美结直肠癌市场预计将从2022年的8,559.27百万美元增长到2028年的11,198.11百万美元；预计 2022 年至 2028 年复合年增长率为 3.4%。
结直肠癌是最常见的癌症之一在遗传和环境因素的综合影响下，常见于个体的致命癌症。北美有相当多的人口被诊断患有结直肠癌。根据美国疾病控制与预防中心 (CDC) 和美国癌症协会的数据，2020 年美国估计有 193 万名成年人被诊断患有结肠癌和直肠癌，53,200 人死于结直肠癌。这些统计数据表明需求增加该地区先进的癌症诊断和治疗。因此，结直肠癌患病率的上升和诊断出该疾病的患者数量的增加正在推动北美结直肠癌市场的增长。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美结直肠癌市场实现大幅复合年增长率。
北美结直肠癌
2028年市场收入及预测（百万美元）
北美结直肠癌市场细分
北美结直肠癌市场分为模式、最终用户和国家。根据模式，北美结直肠癌市场分为诊断类型、治疗类型和影像类型。 2022年，诊断型细分市场占据最大的市场份额，预计在预测期内复合年增长率最高。根据最终用户，北美结直肠癌市场分为医院和诊断与治疗。研究实验室。 2022年，医院细分市场占有更大的市场份额。根据国家/地区，北美结直肠癌市场分为美国、加拿大和墨西哥。 2022 年，美国占据最大市场份额。
雅培、安进公司、布鲁克公司、临床基因组技术有限公司、Epigenomics AG、F. Hoffmann-La Roche AG、Quest Diagnostics 和 VolitionRx Limited 是北美结直肠癌市场的领先公司之一。
Strategic insights for North America Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 8,559.27 Million |
| Market Size by 2028 | US$ 11,198.11 Million |
| Global CAGR (2022 - 2028) | 3.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 方式
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Colorectal Cancer Market is valued at US$ 8,559.27 Million in 2022, it is projected to reach US$ 11,198.11 Million by 2028.
As per our report North America Colorectal Cancer Market, the market size is valued at US$ 8,559.27 Million in 2022, projecting it to reach US$ 11,198.11 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.
The North America Colorectal Cancer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Cancer Market report:
The North America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Colorectal Cancer Market
